Free release
(S)-N1,N3-Bis(1,3-dihydroxypropan-2-yl)-5-(2-hydroxypropanamido)-2,4,6-triiodoisophthalamide

(S)-N1,N3-Bis(1,3-dihydroxypropan-2-yl)-5-(2-hydroxypropanamido)-2,4,6-triiodoisophthalamide

CAS No. :60166-93-0MDL No. :MFCD00867931Formula :C17H22I3N3O8Boiling Point :-Linear Structure Formula :-InChI Key :XQZXY

Sales:Service@apichina.com
CAS No. :60166-93-0 Brand :Qitai
Formula :C17H22I3N3O8 M.W :777.09

Introduction

CAS No. :60166-93-0 MDL No. :MFCD00867931
Formula : C17H22I3N3O8 Boiling Point : -
Linear Structure Formula :- InChI Key :XQZXYNRDCRIARQ-LURJTMIESA-N
M.W : 777.09 Pubchem ID :65492
Synonyms :
B-15000;SQ-13396;Niopam;Isovue;Gastromiro
Chemical Name :(S)-N1,N3-Bis(1,3-dihydroxypropan-2-yl)-5-(2-hydroxypropanamido)-2,4,6-triiodoisophthalamide

Physicochemical Properties

Num. heavy atoms : 31
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.47
Num. rotatable bonds : 13
Num. H-bond acceptors : 8.0
Num. H-bond donors : 8.0
Molar Refractivity : 134.74
TPSA : 188.45 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -12.76 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.65
Log Po/w (XLOGP3) : -2.42
Log Po/w (WLOGP) : -1.21
Log Po/w (MLOGP) : -0.2
Log Po/w (SILICOS-IT) : 2.32
Consensus Log Po/w : -0.17

Druglikeness

Lipinski : 3.0
Ghose : None
Veber : 2.0
Egan : 1.0
Muegge : 4.0
Bioavailability Score : 0.17

Water Solubility

Log S (ESOL) : -2.42
Solubility : 2.96 mg/ml ; 0.00381 mol/l
Class : Soluble
Log S (Ali) : -1.0
Solubility : 78.2 mg/ml ; 0.101 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.96
Solubility : 0.0844 mg/ml ; 0.000109 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 3.61
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram: